Company / Total Assets
ENDRA Life Sciences Inc. Total Assets History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$8.8M
FY2020
5-year range
$6.1M / $8.8M
FY2017-FY2020
Trend
+22.1%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $7M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2020 with a 3-year CAGR of +12.7%.
Improved from $7M to $9M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +12.7%, indicating consistent growth.
- In FY2020, total assets increased 22.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $8.8M | +22.1% |
| FY2019 | $7.2M | -0.6% |
| FY2018 | $7.2M | +17.9% |
| FY2017 | $6.1M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026